RADIOFREQUENCY ABLATION IS EFFECTIVE TREATMENT FOR DYSPLASIA IN BARRETT'S ESOPHAGUS
May 19, 2008
May 19, 2008
CHAPEL HILL, N.C., May 19 -- The University of North Carolina School of Medicine issued the following press release:
Interim results from a nationwide clinical trial led by a University of North Carolina at Chapel Hill researcher suggest that radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer.
"The interim results show there is a substantial difference b . . .
Interim results from a nationwide clinical trial led by a University of North Carolina at Chapel Hill researcher suggest that radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer.
"The interim results show there is a substantial difference b . . .